small-logo
ProfessionalsCapabilitiesInsights & NewsCareersLocations
About UsAlumniOpportunity & InclusionPro BonoCorporate Social Responsibility
Stay Connected:
facebookinstagramlinkedintwitteryoutube

Insights & News

Professionals
Capabilities: Services
Capabilities: Sectors
Capabilities: Regions
Type
Offices
Start Date
End Date

Get Our Updates

Subscribe
View:
Blog
Winston Kicks Off Sixth Cohort of D&I Associate Sponsorship Program and Graduates the Class of 2023-2024

November 25, 2024

Recognitions

Winston Attorneys Recognized in Best Lawyers: Ones to Watch® in America 2025

August 15, 2024

Speaking Engagement
Terry Dee and Courtney Block Present at the 2024 Annual Ethics Program

June 5, 2024

Article
Tylenol MDL Highlights Expert Admissibility Headaches

May 3, 2024

Blog
In re Acetaminophen MDL Court Highlights the Significance of Regulator and Medical Organization Conclusions on Causation in Assessing Expert Methodologies

February 23, 2024

News
2022 Pro Bono Impact Report

May 1, 2023

Blog
Zantac MDL Decision Highlights Need for Rigorous and Objective Approach in Bradford Hill Analyses

February 15, 2023

Blog
Chicago Litigators Spend an Afternoon Giving Back to the Community

October 14, 2022

Press Release
Winston & Strawn Highlights Recent Court Victories for LGBTQ+ Rights

June 2, 2022

Pro Bono In Action
Winston Wins Landmark Victories for Transgender Individuals in Federal Custody

June 2, 2022

Press Release
Winston & Strawn Represents More Than 50 Equality Advocates in Amicus Brief Calling for Publication of Equal Rights Amendment

January 11, 2022

Client Alert
Claiming a Result of the Application of a Natural Law Amounts to a Patent-Ineligible Concept, Rather Than Claiming the Particular Steps of Achieving the Result

September 23, 2020

In the Media
How Women in Big Law Are Stepping Into the Court Fight Over the Equal Rights Amendment

July 2, 2020

Client Alert
Supreme Court Rules Government Must Compensate Health Insurers for ACA Losses

April 30, 2020

Client Alert
There Is No Specific Intent to Induce Infringement Where a Statement of the Infringing Use in the Drug Product Label Is Permissive, Rather Than Mandatory

October 10, 2019

Logo
facebookinstagramlinkedintwitteryoutube

Copyright © 2025. Winston & Strawn LLP

AlumniCorporate Transparency Act Task ForceDEI Compliance Task ForceEqual Rights AmendmentLaw GlossaryThe Oval UpdateWinston MinutePrivacy PolicyCookie PolicyFraud & Scam AlertsNoticesSubscribeAttorney Advertising